-A +A

Alemtuzumab


Trade Names: 
Campath®

Possible Uses: 
Approved for B-Cell chronic lymphocytic leukemia. Also used for T-cell lymphoma and leukemia.

Special Notes: 
Can be given by IV infusion and SQ injection

Drug Interactions: 
echinacea

Possible Side Effects: 
Low blood pressure, edema, fever, chills, fatigue, headache,rash, neasuea, vomiting, diarrhea, mucositis. Lymphopenia is significant as well as neutropenia, anemia, and low platelets. Rigors, cough, and infections can occur.
Last updated on 02/01/2010
BMT InfoNet 2310 Skokie Valley Road, Suite 104, Highland Park, IL 60035 • 888.597.7674 • Fax: 847.433.4599 • help@bmtinfonet.org
All Rights Reserved